Tonix Pharmaceuticals Holding (TNXP) Other Non Operating Income (2012 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted Other Non Operating Income of -$49000.0 for Q2 2026, down 1533.33% on a QoQ basis from -$3000.0 in Q1 2026, and up 97.49% year-over-year from -$24810.9 in Q2 2025.
Powered by 
Analysis
Tonix Pharmaceuticals Holding (TNXP) Other Non Operating Income (2012 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding has reported Other Non Operating Income for 9 years, with the latest figure at -$49000.0 in Q2 2026.
- On a quarterly basis, Other Non Operating Income rose 97.49% year-over-year to -$49000.0 in Q2 2026; TTM through Jun 2026 was -$1.2 million, a 69.52% increase from a year earlier, with the FY2025 full-year figure at -$3.3 million, down 153.58% from the prior year.
- Other Non Operating Income was -$49000.0 for Q2 2026 at Tonix Pharmaceuticals Holding, down from -$3000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $7.0 million in Q1 2024, with the low at -$2.1 million in Q1 2025.
- Average Other Non Operating Income over 4 years is $194923.1, with a median of -$39000.0 recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: Other Non Operating Income surged 680.94% in 2024, then sank 2527.27% in 2025.
- Over 4 years, Other Non Operating Income stood at $7000.0 in 2023, then sank by 728.57% to -$44000.0 in 2024, then grew by 11.36% to -$39000.0 in 2025, then dropped by 25.64% to -$49000.0 in 2026.
- The last three Other Non Operating Income figures came in at -$49000.0 (Q2 2026), -$3000.0 (Q1 2026), and -$39000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | Tonix Pharmaceuticals Holding | 220.65 Mn | 220.65 Mn | 12.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -49,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -39,000.00 |
| Sep 30, 2025 | -1.16 Mn |
| Jun 30, 2025 | -1.96 Mn |
| Mar 31, 2025 | -2.09 Mn |
| Sep 30, 2024 | -44,000.00 |
| Jun 30, 2024 | -855,000.00 |
| Mar 31, 2024 | 7.01 Mn |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 172,000.00 |
| Jun 30, 2023 | 646,000.00 |
| Mar 31, 2023 | 897,000.00 |
| Mar 31, 2016 | -18,000.00 |
| Dec 31, 2015 | 5,000.00 |
| Sep 30, 2015 | -9,000.00 |
| Jun 30, 2015 | -1,000.00 |
| Mar 31, 2015 | -3,000.00 |
| Dec 31, 2014 | -1,000.00 |
| Sep 30, 2014 | 1,000.00 |